Nexium esomeprazole magnesium: Phase III data

In a 12-month, open-label, dose-ranging, international Phase III trial in 19 patients with Zollinger-Ellison syndrome and 2 with idiopathic gastric acid hypersecretion (IGH), 19 patients had controlle...